P921: UPDATED EFFICACY AND SAFETY RESULTS OF TECLISTAMAB, A B-CELL MATURATION ANTIGEN X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM MAJESTEC-1 - J. Martínez-López; P. Moreau; S. Z. Usmani; A. Garfall; N. W. van de Donk; J. F. San-Miguel; A. Oriol; A. Chari; L. Karlin; M.-V. Mateos; R. Popat; A. K. Nooka; et al. (HemaSphere, 2022)